Sally Redshaw
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Computational Drug Discovery Methods, HIV Research and Treatment, Drug Transport and Resistance Mechanisms, Cholinesterase and Neurodegenerative Diseases
Most-Cited Works
- → Rational Design of Peptide-Based HIV Proteinase Inhibitors(1990)925 cited
- → Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere(1991)232 cited
- → Oral administration of a potent and selective non‐peptidic BACE‐1 inhibitor decreases β‐cleavage of amyloid precursor protein and amyloid‐β production in vivo(2006)198 cited
- → The design and synthesis of the Angiotensin Converting Enzyme inhibitor Cilazapril and related bicyclic compounds(1986)100 cited
- → Second Generation of Hydroxyethylamine BACE-1 Inhibitors: Optimizing Potency and Oral Bioavailability(2008)65 cited
- → BACE-1 inhibitors part 3: Identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells(2008)57 cited
- → BACE-1 inhibitors part 2: Identification of hydroxy ethylamines (HEAs) with reduced peptidic character(2008)56 cited
- → Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimetics(2009)54 cited
- → New potent inhibitors of angiotensin converting enzyme(1984)53 cited
- → Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent(2009)49 cited